Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein , arguing the dental and medical distributor needs to start searching for a ...

Henry Schein said it expects to report earnings and revenue growth in the fourth quarter and forecast further gains in 2025 adjusted earnings, even as it confirmed an activist-investment deal with ...

MELVILLE, N.Y., January 29, 2025--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) ("Henry Schein" or the "Company"), the world’s largest provider of health care ...

KKR to invest $250M in Henry Schein, increasing stake to 12%, with an option to reach 14.9%. Henry Schein raises share buyback program by $500M and expects moderate revenue and EPS growth in 2025.

Jan 29 (Reuters) - Private equity firm KKR (KKR.N), opens new tab has taken a large stake in Henry Schein (HSIC.O), opens new tab and reached a deal to add members to the company's board ...

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s ...

Henry Schein (HSIC) announced a strategic investment by funds affiliated with KKR,(KKR) a global investment firm.In addition to KKR’s current holdings, KKR will make an additional $250M ...

In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...

Henry Schein (NASDAQ:HSIC) announced Wednesday a strategic investment from funds affiliated with private equity firm KKR (NYSE:KKR) and released its preliminary Q4 2024 financials and full-year ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...